Bacillus clausii for Prevention of Late-onset Sepsis in Preterm Infants: A Randomized Controlled Trial
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND OF THE STUDY: Preterm infants are managed with antibiotics for sepsis, including suspected or probable sepsis. This leads to a delayed and abnormal colonization of the gut with potentially pathogenic organisms and a microbiome, which lacks biodiversity and increases the risk for late-onset sepsis (LOS). Probiotics have been proven to reduce the risk for necrotizing enterocolitis, but evidence for prevention of LOS is inconclusive. Probiotic effect depends also on the strain used, dose and indication for use. This study evaluated Bacillus clausii probiotic administered prophylactically to preterm neonates for prevention of LOS. OBJECTIVES: To study B.clausii given prophylactically to preterm neonates for prevention of LOS. DESIGN: Double-blinded, placebo-controlled, randomized trial. SETTINGS: Tertiary care neonatal unit in India. PARTICIPANTS: Consecutive preterm neonates <34 weeks, admitted from 1 March 2012 to 28 February 2014 were stratified as extreme preterm and very preterm. INTERVENTION: Randomized to receive either probiotic or placebo for 6 weeks, discharge from hospital, death or occurrence of sepsis, whichever was earlier. PRIMARY OUTCOME: Incidence of definite and probable LOS in probiotic group compared with placebo. RESULTS: Of 326 eligible preterm infants, 244 were enrolled and 82 were excluded. Of these, 120 were stratified as extreme preterm and randomized to receive placebo (n = 59) and probiotic (n = 61). Of 124 babies stratified as very preterm, an equal number was randomized to receive placebo (n = 62) and probiotic (n = 62). There was no significant difference in the incidence of LOS between the two arms in the extreme preterm group [29% vs. 23%; relative risk (RR) 1.27; 95% confidence interval (CI) 0.88-1.66; p = 0.36] and the very preterm group (13% vs. 10%; RR 1.33; 95% CI 0.96-1.70; p = 0.32). Full feeds were achieved significantly faster in the probiotic group in both the extreme preterm (RR 0.82; 95% CI 0.74-0.88) and the very preterm (RR 0.67; 95% 0.32-0.77). CONCLUSIONS: Prophylactic administration of B.clausii to preterm neonates did not result in a significant difference in the incidence of LOS as compared with placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital-acquired neonatal infections in developing countries
Zaidi, A. K., Huskins, W. C., Thaver, D., Bhutta, Z. A., Abbas, Z., & Goldmann, D. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71881-x · Cited by 830 · cited 1×
“Predisposing factors for sepsis include low birth weight, prematurity and admission to intensive care unit, among others [6, 7].”
BackgroundLin, H.-C., Su, B.-H., Chen, A.-C., Lin, T.-W., Tsai, C.-H., Yeh, T.-F., & Oh, W. (2005) · Pediatrics · doi:10.1542/peds.2004-1463 · Cited by 660 · cited 1×
“The Cochrane systematic review in preterm infants found no evidence of significant reduction of nosocomial sepsis probably owing to heterogeneity of the included studies, although earlier randomized controlled trials (RCT) showed a significant difference [19, 20].”
ResultLactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“RCT on preterm supplementation with Bifidobacterium lactis or Lactobacillus containing probiotic have not resulted in a consistent reduction in the risk of LOS, and there are reports of blood culture positive sepsis with the probiotic bacteria [25, 26].”
Background
Cited by
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives
Elshaghabee, F. M. F., Rokana, N., Gulhane, R. D., Sharma, C., & Panwar, H. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01490 · Cited by 940
Morgan, R. L., Preidis, G. A., Kashyap, P. C., Weizman, A. V., Sadeghirad, B., Chang, Y., Florez, I. D., Foroutan, F., Shahid, S., & Zeraatkar, D. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.096 · Cited by 246
Tegegne, B. A., & Kebede, B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09725 · Cited by 232
“A randomized control trial employing a probiotic combination of Bifidobacterium infantis, Streptococcus thermophiles, and Bifidobacterium lactis recently published revealed a substantial reduction in LOS in the preterm subgroup of 28–31 weeks gestation [56].”
BackgroundProbiotic Supplementation and Late-Onset Sepsis in Preterm Infants: A Meta-analysis
Rao, S. C., Athalye-Jape, G. K., Deshpande, G. C., Simmer, K. N., & Patole, S. K. (2016) · Pediatrics · doi:10.1542/peds.2015-3684 · Cited by 201
Probiotics for Preterm Infants: A Strain‐Specific Systematic Review and Network Meta‐analysis
van den Akker, C. H. P., van Goudoever, J. B., Szajewska, H., Embleton, N. D., Hojsak, I., Reid, D., Shamir, R., & ESPGHAN Working Group for Probiotics, P. &. C. O. N. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001897 · Cited by 167
“Three studies (using Ba clausii 4 strains (94); B bifidum OLB6378 (95); and Sa boulardii CNCM I-3799 (100)) had to be excluded from the NMA because there were zero events in both the placebo and intervention groups.”
Metadata
- Authors
- Tewari, V. V., Dubey, S. K., & Gupta, G.
- Venue
- Journal of Tropical Pediatrics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-08-04
- Volume
- 61
- Issue
- 5
- Pages
- 377-385
- ISSN
- 0142-6338 (ISSN-L)
- 1465-3664
- OpenAlex
- W2133218289
- Cited by
- 67
- References
- 3
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.